These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10323266)

  • 1. Expression, secretion, and inhibition of angiotensin-converting enzyme in cultured human bronchial epithelial cells.
    Takimoto M; Mitani H; Hori S; Kimura M; Bandoh T; Okada T
    Eur J Pharmacol; 1999 Apr; 370(2):169-77. PubMed ID: 10323266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodynamic effects of an angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist during hypovolaemia in the anaesthetized pig.
    Ryckwaert F; Colson P; André E; Perrigault PF; Guillon G; Barberis C
    Br J Anaesth; 2002 Oct; 89(4):599-604. PubMed ID: 12393362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of angiotensin I-converting enzyme in cultured bovine bronchial epithelial cells.
    Müns G; Vishwanatha JK; Rubinstein I
    J Cell Biochem; 1993 Dec; 53(4):352-9. PubMed ID: 8300752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II type 1 receptor blockers.
    Burnier M
    Circulation; 2001 Feb; 103(6):904-12. PubMed ID: 11171802
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiotensin-converting enzyme activity in ovine bronchial vasculature.
    Moldobaeva A; Wagner EM
    J Appl Physiol (1985); 2003 Dec; 95(6):2278-84. PubMed ID: 12897028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure.
    Jorde UP; Ennezat PV; Lisker J; Suryadevara V; Infeld J; Cukon S; Hammer A; Sonnenblick EH; Le Jemtel TH
    Circulation; 2000 Feb; 101(8):844-6. PubMed ID: 10694521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-II receptor antagonists: their place in therapy.
    Kirk JK
    Am Fam Physician; 1999 Jun; 59(11):3140-8. PubMed ID: 10392595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of enalapril and valsartan in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
    Lassila M; Finckenberg P; Pere AK; Krogerus L; Ahonen J; Vapaatalo H; Nurminen ML
    Br J Pharmacol; 2000 Jul; 130(6):1339-47. PubMed ID: 10903974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets.
    Lupi R; Del Guerra S; Bugliani M; Boggi U; Mosca F; Torri S; Del Prato S; Marchetti P
    Eur J Endocrinol; 2006 Feb; 154(2):355-61. PubMed ID: 16452552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic treatment with losartan and enalaprilat on [3H]-norepinephrine release from isolated atria of Wistar-Kyoto and spontaneously hypertensive rats.
    Foucart S; Patrick SK; Oster L; de Champlain J
    Am J Hypertens; 1996 Jan; 9(1):61-9. PubMed ID: 8834708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved glucose metabolism following blockade of angiotensin converting enzyme but not angiotensin AT1 receptors.
    Chow L; De Gasparo M; Levens N
    Eur J Pharmacol; 1995 Aug; 282(1-3):77-86. PubMed ID: 7498292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial bradykinin following acute angiotensin-converting enzyme inhibition, AT1 receptor blockade, or combined inhibition in congestive heart failure.
    Multani MM; Krombach RS; Goldberg AT; King MK; Hendrick JW; Sample JA; Baicu SC; Joffs C; deGasparo M; Spinale FG
    J Cardiovasc Pharmacol Ther; 2001 Oct; 6(4):369-76. PubMed ID: 11907639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
    Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
    Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of endothelial autacoid formation by inhibitors of angiotensin-converting enzyme.
    Hecker M; Benzing T; Busse R
    Agents Actions Suppl; 1992; 38 ( Pt 3)():163-70. PubMed ID: 1281378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibition modulates high-glucose-induced extracellular matrix changes in mouse glomerular epithelial cells.
    Morano S; Cipriani R; Cerrito MG; Santangelo C; Vasaturo F; Pantellini F; Sensi M; Guidobaldi L; Scarpa S; Di Mario U
    Nephron Exp Nephrol; 2003; 95(1):e30-5. PubMed ID: 14520012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE inhibition and fibroblast growth factor in cultured human vascular smooth muscle.
    Tang L; Both K; Taylor R
    Vasc Med; 1999; 4(3):129-34. PubMed ID: 10512591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide donors and angiotensin-converting enzyme inhibitors act in concert to inhibit human angiotensin-converting enzyme activity and platelet aggregation in vitro.
    Persson K; Whiss PA; Nyhlén K; Jacobsson-Strier M; Glindell M; Andersson RG
    Eur J Pharmacol; 2000 Oct; 406(1):15-23. PubMed ID: 11011027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of serum angiotensin-converting enzyme in rabbits after intravenous administration of enalaprilat-loaded intact erythrocytes.
    Hamidi M; Tajerzadeh H; Dehpour AR; Ejtemaee-Mehr S
    J Pharm Pharmacol; 2001 Sep; 53(9):1281-6. PubMed ID: 11578111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE.
    Ceconi C; Francolini G; Olivares A; Comini L; Bachetti T; Ferrari R
    Eur J Pharmacol; 2007 Dec; 577(1-3):1-6. PubMed ID: 17716647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.